Synergistic Antitumor Effect of Doxorubicin and Tacrolimus (FK506) on Hepatocellular Carcinoma Cell Lines

Hepatocellular carcinoma is the fifth most common cancer worldwide and shows a complex clinical course, poor response to pharmacological treatment, and a severe prognosis. Thus, the aim of this study was to investigate whether tacrolimus (FK506) has synergistic antitumor effects with doxorubicin on...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Capone, Francesca, Guerriero, Eliana, Sorice, Angela, Colonna, Giovanni, Storti, Gabriella, Pagliuca, Jessica, Castello, Giuseppe, Costantini, Susan
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2014
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3951002/
https://ncbi.nlm.nih.gov/pubmed/24701168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/450390
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars